戻る Agenda
The Impact of Innovation and Novel Pathways: The Role of the Regulator
Session Chair(s)
Ian Hudson
Senior Advisor, Integrated Development
Bill and Melinda Gates Foundation, United States
The International Coalition of Medicines Regulatory Authorities (ICMRA) will explore role of regulators in the current international landscape, including the impact of innovation and novel pathways. The session will be delivered by members of ICMRA who represent a number of leading regulators across Europe and beyond.
Speaker(s)
Horizon Scanning: Methodologies and Best Practice
Tatsuya Kondo, MD, PHD
SH Medical Excellence JAPAN, Japan
President
Leveraging Outcomes of Horizon Scanning
Agnès Saint-Raymond, DrMed
European Medicines Agency, Netherlands
Head of Division International Affairs
Novel Approaches to Licensing
John Patrick Stewart, MD
Health Canada, Canada
Director General, Marketed Health Products Directorate, HPFB
Overview of Projects
Lorraine Nolan, PHD
Health Products Regulatory Authority , Ireland
Chief Executive